CTCE 9908 acts as a CXCR4 antagonist that induces mitotic catastrophe in ovarian cancer cells. When given with taxol, it displays additive cytotoxic effects.
CAT No: R0977
CAS No:1030384-98-5
Synonyms/Alias:CTCE 9908;1030384-98-5;CTCE-9908;UNII-NF0BX95A31;L-Lysinamide, N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-;NF0BX95A31;PTX-9908 FREE BASE;CTCE 9908 TFA;CTCE9908;SDF-1 Analog PTX-9908;CHEMBL3544949;SDF-1 (108) Lysine Dlmer;CXCR4 Antagonist CTCE-9908;PTX9908;PTX 9908;PTX-9908;SDF-1 Receptor Antagonist PTX-9908;DA-52152;G14352;Q27284835;L-Lysinamide,N2,N6-bis(L-lysylglycyl-L-valyl-L-seryl-L-leucyl-L-seryl-L-tyrosyl-L-arginyl)-;
4. Immune responses to homocitrulline-and citrulline-containing peptides in rheumatoid arthritis
5. An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.